Positive News SentimentPositive News ORIC Pharmaceuticals (ORIC) News Today $8.27 +0.37 (+4.68%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$7.65▼$8.3050-Day Range$5.41▼$8.2752-Week Range$2.91▼$9.79Volume412,571 shsAverage Volume371,698 shsMarket Capitalization$451.13 millionP/E RatioN/ADividend YieldN/APrice Target$16.29 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Rating of "Buy" from Analystsamericanbankingnews.com - November 24 at 1:24 AMORIC Pharmaceuticals Inc ORICmorningstar.com - November 9 at 8:00 PMAnalysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL), Oric Pharmaceuticals (ORIC) and Acadia Healthcare (ACHC)markets.businessinsider.com - November 8 at 2:03 PMORIC Pharmaceuticals GAAP EPS of -$0.44msn.com - November 6 at 9:49 PMORIC Pharmaceuticals Inc (ORIC) Reports Q3 2023 Financial Results and Operational Updatesfinance.yahoo.com - November 6 at 9:49 PMORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updatesfinance.yahoo.com - November 6 at 4:49 PMORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meetingfinance.yahoo.com - November 2 at 9:17 AMWedbush Reiterates ORIC Pharmaceuticals (ORIC) Outperform Recommendationmsn.com - October 23 at 10:05 PMAnalyst Expectations for ORIC Pharmaceuticals's Futuremarkets.businessinsider.com - October 23 at 12:05 PMInitial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profilefinance.yahoo.com - October 21 at 12:45 PMORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023finance.yahoo.com - October 17 at 8:27 PMOric Pharmaceuticals, Inc. (ORIC) Upgraded to Buy: What Does It Mean for the Stock?finance.yahoo.com - October 16 at 2:01 PMNextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhDfinance.yahoo.com - September 26 at 11:41 AMORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conferencebenzinga.com - September 20 at 7:47 PMORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conferencefinance.yahoo.com - September 20 at 7:47 PMNavigating ORIC's Robust Strategy Against Cancer Drug Resistancemsn.com - September 13 at 9:18 PMAtom Investors LP Decreases Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - September 11 at 6:26 AMOric Pharmaceuticals (ORIC) Receives a Buy from Robert W. Bairdmarkets.businessinsider.com - August 17 at 8:10 AMBaird Maintains ORIC Pharmaceuticals (ORIC) Outperform Recommendationmsn.com - August 16 at 10:10 PMH.C. Wainwright Sticks to Its Buy Rating for Oric Pharmaceuticals (ORIC)markets.businessinsider.com - August 15 at 8:13 AMMarkets Today: Stocks Fall on a Hot U.S. July PPImsn.com - August 11 at 3:50 PMORIC Pharmaceuticals GAAP EPS of -$0.50 beats by $0.08msn.com - August 11 at 6:56 AMORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updatesfinance.yahoo.com - August 11 at 1:55 AMVictory Capital Management Inc. Purchases New Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - August 10 at 5:12 AMORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - August 4 at 7:19 PMJacob Chacko Sells 4,336 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Stockmarketbeat.com - July 7 at 5:36 PMWhy Oric Pharmaceuticals Stock Is Shooting Higher Todaymarkets.businessinsider.com - June 28 at 9:46 AMWhy Shares of Oric Pharmaceuticals Jumped Mondayfinance.yahoo.com - June 26 at 5:40 PMORIC Pharmaceuticals launches ~$85M private placement of shares, warrantsseekingalpha.com - June 26 at 12:39 PMORIC Pharma Surges On $85 Mln Private Placement Financingmarkets.businessinsider.com - June 26 at 12:39 PMORIC Pharmaceuticals Announces $85 Million Private Placement Financingfinance.yahoo.com - June 26 at 12:39 PMHC Wainwright & Co. Reiterates ORIC Pharmaceuticals (ORIC) Buy Recommendationmsn.com - June 8 at 6:17 PMCornercap Investment Counsel Inc. Sells 22,606 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - June 2 at 8:26 AMORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conferencefinance.yahoo.com - May 31 at 4:39 PMHC Wainwright & Co. Maintains ORIC Pharmaceuticals (ORIC) Buy Recommendationmsn.com - May 12 at 10:43 AMORIC Pharmaceuticals, Inc. Forecasted to Post Q2 2023 Earnings of ($0.59) Per Share (NASDAQ:ORIC)marketbeat.com - May 12 at 7:55 AMORIC Pharmaceuticals GAAP EPS of -$0.53msn.com - May 8 at 9:21 PMORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updatesfinance.yahoo.com - May 8 at 4:21 PMORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - May 5 at 7:16 PMBank of Montreal Can Invests $636,000 in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - May 1 at 4:49 AMORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conferencefinance.yahoo.com - April 25 at 6:47 PMMonaco Asset Management SAM Raises Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)marketbeat.com - April 20 at 4:53 AMORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meetingfinance.yahoo.com - April 18 at 8:32 PMCitigroup Maintains ORIC Pharmaceuticals (ORIC) Buy Recommendationmsn.com - April 6 at 9:00 AMOne ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) insider upped their stake by 128% in the previous yearfinance.yahoo.com - March 31 at 12:42 PM‘Charts Point to Higher Highs,’ Says Oppenheimer. Here Are 2 Stocks With Over 100% Upside Potentialfinance.yahoo.com - March 29 at 11:50 PMQ1 2023 Earnings Estimate for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Issued By HC Wainwrightmarketbeat.com - March 24 at 6:17 AM4 Analysts Have This to Say About ORIC Pharmaceuticalsmarkets.businessinsider.com - March 23 at 12:01 PMORIC Pharmaceuticals (NASDAQ:ORIC) Given New $15.00 Price Target at JPMorgan Chase & Co.marketbeat.com - March 21 at 10:32 AMAnalysts Offer Insights on Healthcare Companies: Neoleukin Therapeutics (NLTX), RAPT Therapeutics (RAPT) and Oric Pharmaceuticals (ORIC)markets.businessinsider.com - March 21 at 7:34 AM Get ORIC Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address ORIC Media Mentions By Week ORIC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORIC News Sentiment▼1.870.76▲Average Medical News Sentiment ORIC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORIC Articles This Week▼11▲ORIC Articles Average Week Get ORIC Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Phibro Animal Health News Today Phathom Pharmaceuticals News Today Lyell Immunopharma News Today Seelos Therapeutics News Today Bicycle Therapeutics News Today 23andMe News Today Edgewise Therapeutics News Today Silence Therapeutics News Today Entrada Therapeutics News Today SIGA Technologies News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ORIC) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.